HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

spinner

Media tagged with "levels"

CDC

Very High Blood Lead Levels Among Adults - United States,2002-2011 lead  adults  among  very  blood  levels 

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.

Preview   0 Users liked this content.
CDC

Preventing Chronic Disease | Trends in Tobacco Smoke Exposure and Blood Lead Levels Among Youths and Adults in the United States: The National Health and Nutrition Examination Survey, 1999"2008 - CDC lead  youth  health  survey  disease  chronic  adults  states  tobacco  smoke  smoking  CDC  cigarette  national  among  trends  blood  levels  exposure  youths 

Tobacco smoke is a source of exposure to thousands of toxic chemicals including lead, a chemical of longstanding public health concern. We assessed trends in blood lead levels in youths and adults with cotinine-verified tobacco smoke exposure by using 10 years of data from the National Health and Nutrition Examination Survey.

Preview   0 Users liked this content.
CDC

Assessment of Blood Lead Levels Among Children Aged ?5 Years— Zamfara State, Nigeria, June–July 2012 lead  state  children  assessment  years  among  nigeria  blood  levels  zamfara  junejuly 

Muhammed Bashir, MD1, Nasir Umar-Tsafe, MSc1, Kabiru Getso, MBBS1, Ibrahim M. Kaita, MSc1, Abdulsalami Nasidi, PhD2; Nasir Sani-Gwarzo MD2; Patrick Nguku, MD3, Lora Davis, DVM3, Mary Jean Brown ScD4 (Author affiliations at end of text).

Preview   0 Users liked this content.
NCI

Levels of Evidence for Adult and Pediatric Cancer Treatment Studies (PDQ®)–Health Professional Version cancer  health  treatment  adult  levels  pediatric  evidence  version  professional  studies  evaluation of evidence  Levels of Evidence 

Information about how to weigh the strength of the evidence obtained in different kinds of cancer treatment studies.

Preview   0 Users liked this content.
NCI

Levels of Evidence for Human Studies of Integrative, Alternative, and Complementary Therapies (PDQ®)–Health Professional Version cancer  health  alternative  complementary  levels  human  evidence  version  professional  studies  medicine  evaluation of evidence  Levels of Evidence 

Information about how to weigh the strength of the evidence obtained in human studies of integrative, alternative, and complementary therapies for cancer.

Preview   0 Users liked this content.
NCI

Levels of Evidence for Cancer Screening and Prevention Studies (PDQ®)–Health Professional Version cancer  prevention  health  levels  screening  evidence  version  professional  studies  evaluation of evidence  Levels of Evidence 

Information about how to weigh the strength of the evidence obtained in cancer screening and prevention research studies.

Preview   0 Users liked this content.
NCI

Levels of Evidence for Supportive and Palliative Care Studies (PDQ®)–Health Professional Version health  care  levels  evidence  version  professional  studies  palliative  evaluation of evidence  Levels of Evidence 

Information about how to weigh the strength of the evidence obtained in supportive and palliative care studies.

Preview   0 Users liked this content.
NCI

Levels of Evidence for Cancer Genetics Studies (PDQ®)–Health Professional Version cancer  health  levels  evidence  version  professional  studies  genetics  evaluation of evidence  Levels of Evidence 

Information about how to weigh the strength of the evidence obtained in cancer genetics research studies.

Preview   0 Users liked this content.
CDC

Minimal Risk Levels for Hazardous Substances (MRLs) health effects  health  disease  effects  risk  toxic  body  data  adverse  levels  acute  exposure  human  screening  public  environmental  renal  ATSDR  substances  oral 

An MRL is an estimate of the daily human exposure to a hazardous substance that is likely to be without appreciable risk of adverse noncancer health effects over a specified duration of exposure. These substance-specific estimates, which are intended to serve as screening levels, are used by ATSDR health assessors and other responders to identify contaminants and potential health effects that may be of concern at hazardous waste sites.

Preview   0 Users liked this content.
>> Click here to get embed code for this tag